Modern medicine enables to examine precisely various disease conditions in high detail. The rapid development of diagnostic techniques such as laboratory and imaging methods on the one hand and a daily growing selection of highly specific treatment options on the other hand have brought many changes into Medicine over the last decades.

We thus aim to integrate high-end-technical facilities with the most individualized treatment carried out by our team of internationally renowned experts covering the following fields of internal medicine:


  • Cancers of the female mammary gland (breast cancer).
  • Cancers of the digestive tract (e.g. carcinomas of the colon, rectum, anus, stomach, pancreas, gall bladder, biliary tract, liver).
  • Cancers of the female genital tract (e.g. ovarian carcinomas, uterine carcinomas, cervical carcinomas).
  • Cancers of the male genital tract (e.g. prostate cancer, testicular cancers).
  • Cancers of the endocrine glands (e.g. carcinoids, thyroid carcinomas).
  • Cancers of the respiratory tract (e.g. bronchial carcinomas).
  • Cancers of the urinary tract (e.g. renal cell carcinomas, urothelium cancer of renal pelvis, ureter and urinary bladder).
  • Also for patients with ENT tumors, brain tumors, tumors of the skin (melanoma, Merkel-cell carcinoma) and sarcomas of soft tissue, bone and connective tissue treatments is available.
  • Moreover, there is also expertise and experience regarding rare cancers not listed here.


  • Lymphoproliferative disorders (e.g. chronic lymphocytic leukemia, hairy cell leukemia, prolymphocytic leukemia, multiple myeloma)
  • Myeloproliferative disorders (e.g., chronic myeloid leukemia, myelofibrosis, thrombocythaemia, polycythemia vera)
  • Lymphomas (Hodgkin's and Non-Hodgkin's Lymphomas)
  • Myelodysplastic and aplastic syndromes (MDS, aplastic anemia, PNH)
  • Diseases due to increased or decreased formation of platelets
  • Diseases due to increased or decreased leukocyte formation
  • Diseases due to increased formation of red blood cells (polyglobulia).
  • Anemias (such as haemopathies, globinopathies, membranopathies and enzyme deficiencies including thalassemia, sickle cell anemia, spherocytosis, glucose-6-phosphate dehydrogenase deficiency, pyruvate kinase deficiency, porphyria, iron deficiency, deficiencies of vitamins important for blood cell formation (e.g. vitamin B12 and folic acid deficiency)
  • Disorders of iron metabolism (hemochromatosis and secondary hyperferritinemia)
  • Disorders of copper metabolism (Wilson'd disease)


  • Disorders of blood coagulation (i.e. diseases characterized either by increased coagulation with thrombosis or by impaired coagulation with increased bleeding tendency).
  • Bleeding disease and other deficiency factor deficiencies (e.g., von Willebrand-Jürgens disease, hemophilia, thrombasthenia)
  • Thrombophilia (this includes not only the causal diagnosis of thrombosis but also the risk assessment of thrombosis in pregnancy, for example)


  • Autoimmune diseases such as autoimmune hemolysis, autoimmune thrombocytopenia, autoimmune neutropenia, rheumatic diseases, collagenoses, vasculitis, autoimmune inflammatory bowel disease, autoimmune liver and thyroid disorders, neuroimmunological disorders.
  • Antibody deficiency states (primary and secondary).
  • Monoclonal or polyclonal gammopathies.
  • Disorders of cell-mediated immunity.
  • Lysosomal storage disorders (sphingolipidoses (e.g., M. Fabry, M. Gaucher), amyloidosis, mucopolysaccharidoses.

Check-up program (disease prevention)

The goal is to define risk factors in supposedly "healthy" individuals to prevent the onset of diseases or to delay the time of their manifestation. A wide range of diseases are examined in order

  • to minimize the risk to experience cardiovascular diseases (e.g. myocardial infarction, hypertension, stroke),
  • to early detect the risk for metabolic disorders (e.g. disturbances of lipid metabolism, diabetes,
  • to fight overweight,
  • to optimize treatment of an already established disorders.

© 2019 Onkologikum-Muenchen.de

Imprint & privacy policy

© 2019 onkologikum-muenchen.de


  • Onkologikum München
  • ​Menzingerstrasse 37
  • ​80638 München

  • office hours
  • Onkologikum München
  • ​Menzingerstrasse 37
  • 80638 München

  • office hours
  • by appointment

© 2019 onkologikum-muenchen.de

Imprint & privacy policy